Boots to make major changes to 150 of its stores
Boots will introduce dedicated 'menopause zones' to 150 stores this summer, Retail Gazette reports. The move will see signage added to guide shoppers through a range of products designed to treat or alleviate menopause symptoms.
The menopause zones will also feature new products as well as increased customer services and expertise related to menopause. Products in the collection include hair products, sleep aids and food supplements.
Menopause is when your periods stop due to lower hormone levels.
READ MORE: Mum shares 'hack of the century' to blow up inflatable pool without a pump
READ MORE: 'Biggest prize in the country' coming to city's waterfront
It usually affects people between the ages of 45 and 55, but it can happen earlier.
Perimenopause is when you have symptoms of menopause but your periods have not stopped.
According the the NHS: 'Menopause and perimenopause can cause symptoms like anxiety, mood swings, brain fog, hot flushes and irregular periods. These symptoms can start years before your periods stop and carry on afterwards.'
Part of Boots' new 'zone' system will include signposting sections by symptom including 'vaginal dryness', hot flushes' and 'low energy'.
Products already in Boots' menopause collection include Dr Wolff's 'V-san' moisturizing cream, Boots' evening primrose oil capsules and Pantene's 'hair biology' mask.
There is also a hot and cold compress on sale which is aimed at alleviating discomfort from hot flushes.
The new menopause zones will feature 35 new products including from the brands Balance Activ, Luna Daily and Canesmeno.
The brand M-Club also has an existing range of products such as caffeine shampoo.
Menopause has received increased attention in the media and health reporting in recent years with many women pointing out a lack of awareness surrounding its symptoms and wider impacts.
According to the Chartered Institute for Personnel Development: "Three in five workers experiencing menopause believe it has had a negative impact on them at work.
"But only a quarter of workers, who have missed time due to menopause symptoms, have felt able to tell their employer the real reason for their absence."
Columnist Sarah Sandison wrote for the ECHO in 2023 that 'women are suffering in silence during the menopause and perimenopause'.
She said: 'Everybody needs to be educated on perimenopause and much more needs to be done to recognise any issues and difficulties caused by changing hormones in women, during this time.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 days ago
- Yahoo
3 dead in 2 Orange County crashes Monday
Two crashes in Orange County on Monday morning left three people dead and one injured, according to the Florida Highway Patrol. One two-vehicle crash occurred at 6:19 a.m. shutting down part of West Colonial Drive near Hiawassee Road for hours when a westbound vehicle attempted a left-hand turn, but was struck by an eastbound car. Killed were a 53-year-old Orlando man who was driving a 2015 Jeep Compass as well as a 51-year-old woman who was a passenger in the Jeep, FHP stated. The Jeep had just exited the the turn lane just west of Hiawassee Road and it was struck on its right side by a 2013 Nissan Maxima driven by a 21-year-old Ocoee man. The Jeep passenger was pronounced deceased on scene while the driver was transported to Heath Central Hospital, where he was declared dead, FHP said. The Maxima driver was transported to Orlando Regional Medical Center with serious, but not life-threatening injuries. The crash remains under investigation. The other crash occurred at 6:16 a.m. in a parking lot off of Lake Ellenor Drive near Diplomacy Row, according to an FHP crash report. Killed in the single-vehicle crash was 64-year-old Orlando man who may have suffered a medical episode causing the 2000 Honda CR-V he was driving to collide with a column in front of a building, the report stated. He was transported to ORMC and pronounced dead. The crash also remains under investigation.
Yahoo
31-05-2025
- Yahoo
I'm all set for my summer holiday thanks to this bargain Boots beauty box packed with travel minis
If you could do with a bit of a beauty restock you really need to check out Boots who have just released a range of excellent value beauty boxes. While last week our top pick was the Boots Pamper Beauty Box which contains 10 luxury skincare essentials worth £156 for just £40. Boots has just launched a Hello Summer beauty box filled with a range of travel skincare and make-up minis you need for your summer getaway. Not only is it extremely helpful to remind you that yes, you do need to pack a mini perfume, but having these seven handy mini products means you won't have to wrestle with your suitcase either. Ranging from glow-boosting skincare to mood-lifting fragrance and hydrating essentials, this curated collection is your ultimate holiday-ready refresh. From glow-boosting skincare to mood-lifting fragrance and hydrating must-haves, this curated collection has all your holiday minis sorted. Whether you're jet-setting or stay-caying, these minis are bound to come in handy and will ensure your skin stays hydrated, glowing, and smelling like summer. All housed in a reusable see-through zip pouch, it's also incredibly practical for going through security and will keep your items safe. For starters, let's talk about the excellent value - you're getting seven premium skincare and make-up minis from brands like MAC, Bobbi Brown, Rituals, Laneige, Floral Street, and more for just £32. That works out to just under £4.60 per mini. There's no denying the value in this box, as the same travel-sized Laneige Water Bank Blue Hyaluronic Cream Moisturiser usually retails for £19.50. The Milk Makeup Multi-Use Lip + Cheek Cream Stick retails for £22 and the Floral Street Sunflower Pop Eau de Parfum retails for a whopping £29. Now, let's get into some of my favourite items. Firstly, I'm a massive fan of the Milk Lip + Cheek Tint - it has been one of my holy grail make-up products for years. This shade is a lovely light blush that would look great on all skin tones, and I love that it's two-in-one, so you can use it on both your lips and cheeks and be ready to go. It's ideal, especially when you're on your summer holiday and prefer lighter make-up. I also wasn't expecting to like the MAC mascara as much as I do. It has a great dual-sided curved brush that captures every lash for enhanced lift, and I found it offers a buildable, clump-free finish that had instant results. Shop now The Laneige moisturiser was lightweight and fast-absorbing - two standout qualities of a great moisturiser - and I found it kept my skin well hydrated. It also paired well with the Bobbi Brown Vitamin Enriched Face Base primer that is infused with glow-boosting vitamins and hydration heroes. Next onto scents, while the Floral Street Sunflower Pop Eau de Parfum has over 100 five-star reviews with shoppers saying it 'smells amazing' and like 'summer in a bottle', it was a tad too strong for me. It's described as a 'vibrant, sumptuous citrus blend', designed to bring to life the beauty and optimism of Van Gogh's 'Sunflowers'. Milk - Lip + Cheek In The Shade Werk Full Size (6 g) MAC - Stack Elevated Mascara Mini (8 ml) Bobbi Brown - Vitamin Enriched Face Base (15 ml) Laneige - Water Bank Blue Hyaluronic Cream Moisturiser (20 ml) Floral Street - Sunflower Pop EDP (10 ml) Sol De Janeiro - Cheirosa 62 (30 ml) Rituals - The Ritual Of Karma Shimmering Body Oil (30 ml) I much preferred the extremely popular Sol de Janeiro Cheirosa 62 Perfume Mist, which also smells like summer with warming notes of pistachio, almond, salted caramel and vanilla. Lastly, the Rituals Shimmering Body Oil refreshed my dull-looking skin with a subtle shimmer for a healthy, luminous glow. I'll definitely use it when wearing skirts or for special occasions to add a little extra radiance. Shop now Get your hands on 10 luxury skincare and body care heroes from big-name brands like No7, Liz Earle, Byoma and more, and enjoy some well-deserved TLC. Keep your skin fresh, hydrated, and protected this summer with nine super-charged skincare favourites from the likes of Inkey List, Byoma, Beauty of Joseon and more. The beauty box from Boots is all about self-care and indulgence, featuring 12 skincare, haircare and bodycare treats. Customers who have been quick to snap up the "amazing value" box have nothing but praise, with one five-star review saying it's "a rare beauty box with everything you can use or need!" One shopper has even gone back and bought four more boxes, to give as presents for Christmas. The Boots X Women's Health Beauty + Wellness Edit is packed with self-care essentials designed to refresh and energise you. It includes 12 products and 10 of them in full size! Featuring standout health and beauty picks from top brands like No7, Collagen Gold, and Sol de Janeiro, this box has everything you need to recharge and feel your latest box is a perfect for any sports enthusiast and is epic value for money. Showcasing a huge range of sport nutrition needs from protein powder to electrolytes, this box covers all bases across pre, during and post workout. If it's hair care you're in need of, this is one epic beauty box not to miss. This edit includes everything you need to achieve glossy looking locks that look and feel healthy. Inside you'll find 10 hair care gems that will help to nourish, add shine and repair.
Yahoo
30-05-2025
- Yahoo
Kane Biotech Announces First Quarter 2025 Financial Results
WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ('Kane Biotech', 'Kane' or the 'Company') today announces its first quarter 2025 financial results. First Quarter 2025 Financial Highlights (Comparatives Exclude Discontinued STEM Animal Health 'STEM' Operations): Total revenue for the three months ended March 31, 2025 was $412,513 compared to $51,886 in the three months ended March 31, 2024. Revenue in the current quarter consists primarily of contract animal health manufacturing revenue for Dechra Veterinary Products, Inc. Gross profit for the first quarter of 2025 was $42,447, compared to a gross profit of $40,051 for the first quarter of 2024. Total operating expenses for the three months ended March 31, 2025 were $1,203,505 compared to $1,228,153 for the three months ended March 31, 2024. Net loss for the first quarter of 2025 was $(1,218,497) compared to a net loss of ($1,346,825) for the quarter ended March 31, 2024. Kane Biotech's March 31, 2025 Financial Statements and the Management Discussion and Analysis with regards thereto are now available on SEDAR+ and the Company's website. Corporate Update: On April 28, 2025, the Company outlined a restructuring strategy that focuses primarily on the four verticals of is revyve™ biofilm dispersion technology-based wound care product portfolio. On May 5, 2025, the company closed and received the funds related to its previously announced $1.2 million private placement and $1.0 million unsecured loan and has continued to execute on a number of cost reduction initiatives including a reduction in overhead and other areas which will materially reduce monthly operating costs going forward. As part of their commitment to the Company, on May 9, 2025, two insiders of the company, Dr. Robert Huizinga and Mr. Philip Renaud surrendered 1,750,000 and 1,622,095 respectively of their outstanding RSUs for cancellation. Kane Biotech announced on April 28, 2025 that the CEO was no longer with the Company. The former CEO recently filed and served a legal action for $445,000 related to his employment agreement with Kane Biotech. The action will be vigorously defended. 'We are executing on the restructuring strategy announced earlier this year with discipline and focus. This strategy will allow us to create value for shareholders by focusing on commercial opportunities in the US,' said Dr. Robert Huizinga, Interim CEO. 'We have streamlined our operations to preserve cash, strengthened our financial position, and have aligned our resources with our highest-priority programs, namely our revyve™ product line. We remain committed to strengthening our product distributor relationships, advancing our pipeline and delivering long-term value to patients, partners, and shareholders.' About Kane Biotech Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds which results in serious clinical outcomes and significant cost. revyve™ addresses both biofilms and wound bacteria. For more information: Dr. Robert Huizinga Ray Dupuis Interim CEO Chief Financial Officer Kane Biotech Inc. Kane Biotech Inc. rhuizinga@ rdupuis@ (780) 970-1100 (204) 298-2200 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking InformationThis press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management's current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company's: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at The Company cautions that the foregoing list of factors that may affect future results is not in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
